Double duty for blood pressure drugs: how they could revolutionize how we treat valve disease

Links shared publicly online about this topic.

  • 0
    total visits

Double duty for blood pressure drugs: how they could revolutionize how we treat valve disease

eurekalert.org —

A type of medication known as angiotensin-receptor blockers could reduce risk of mortality in people with a heart disease called calcific aortic stenosis (AS) by 30 per cent over an eight-year period, Heart and Stroke Foundation researcher Dr. Philippe Pibarot told delegates at the Canadian Cardiovascular Congress. The condition is currently managed with open heart surgery.

View full resource at eurekalert.org

Tags: Heart, Heart Disease, Disease and Condition, Drug, Mortality, disease

  • Share

Most Recently Shared on October 25, 2011 at 5:23 am By:

HeartDisease_OW Heart Disease OW

Double duty for blood pressure drugs: how they could revolutionize how we treat valve disease: ( Heart and Strok... http://t.co/uvj0fZ3u

7 months ago...

Reply

Retweet

Favorite

Double duty for blood pressure drugs: study finds they could revolutionize how we treat valve disease. - Heart and Stroke Foundation of Canada

heartandstroke.com — “Here is the latest news from the Canadian Cardiovascular Congress 2011 in Vancouver, British Columbia. The Heart and Stroke Foundation, a volunteer-based health charity, leads in eliminating heart disease and stroke and reducing their impact through the advancement of research and its application, the promotion of healthy living and advocacy.” View full resource at heartandstroke.com

  • View Related
  • Share

Most Recently Shared on October 27, 2011 at 3:06 pm By:

TheHSF Heart and Stroke FDN Health Organization

Study finds they could revolutionize how we treat valve disease: http://t.co/kzQ3aE1i

7 months ago...

Reply

Retweet

Favorite

Advertisement